+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)



In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42)



Neurobiology of Aging 20(3): 325-30; Discussion 339-42



The amyloid beta-peptide (Abeta)-associated free radical oxidative stress model for neuronal death in Alzheimer's disease (AD) brain predicts that neuronal protein oxidation is a consequence of Abeta-associated free radicals (8). In this study we have used both in vitro and in vivo models of beta-amyloid (Abeta) toxicity to detect free radical induced oxidative stress by the measure of protein carbonyl levels.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010812312

Download citation: RISBibTeXText

PMID: 10588580


Related references

In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders. Free Radical Biology and Medicine 41(11): 1694-1703, 2006

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP. Free Radical Biology and Medicine 48(1): 136-144, 2010

Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress. Proteomics. Clinical Applications 2(5): 685-696, 2008

Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Journal of Neurochemistry 96(5): 1322-1335, 2006

Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. Journal of Alzheimer's Disease 4(3): 193-201, 2002

Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. American Journal of Pathology 152(4): 871-877, 1998

Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiology of Aging 25(5): 563-568, 2004

Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biology 14: 450-464, 2018

Roles of amyloid beta-peptide-associated oxidative stress and proteomics-identified brain protein oxidative modifications in the pathogenesis of Alzheimer's disease. 2007

Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease. Methods in Enzymology 309: 746-768, 1999

Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's disease. Protein and Peptide Letters 11(3): 257-270, 2004

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. Progress in Neurobiology 62(6): 633-648, 2000

Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity. Biochimica et Biophysica Acta 1586(2): 190-198, 2002

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. Journal of Structural Biology 130(2-3): 184-208, 2000

Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Chemical Research in Toxicology 17(12): 1743-1749, 2004